Search

everythinglearnresearchcommunity

for

Search:↓

Doctors should prescribe cheaper, off-label medication and teach patients how to use it to save money ethically.

European patent law now allows patents for new uses and dosages of known drugs, but protection scope is unclear.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

The best long-lasting results in treating hair loss may be achieved through combination therapy, including treatments like finasteride, minoxidil, and platelet-rich plasma injections.

Citrullus colocynthis and Citrullus lanatus have potential health benefits but may also cause reproductive toxicity.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Topical treatments for hair loss can be effective but need careful safety evaluation.

The anti-hair loss shampoo effectively promotes hair growth and improves hair quality.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Nanotechnology shows promise for better drug delivery and cancer treatment.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Obesity in the U.S. is largely influenced by diet and exercise, certain medications can improve heart procedures and hair growth, and major teaching hospitals have better patient outcomes.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Men with severe hair loss may have poorer sperm quality.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Using β-cyclodextrin derivatives improves the solubility and bioavailability of steroidal drugs.

Hair follicle regeneration possible, more research needed.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Isotretinoin and acitretin may effectively stabilize the hairline in patients with frontal fibrosing alopecia.

The HairCheck® device is effective for measuring hair loss and growth in people with alopecia.